Schott Pharma AG KGaA (CHIX:1SXPD) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:1SXPD Schott Pharma AG & CO KGaA CHIX:1SXPD
71 GF Score
Price €14.47
GF Value €20.10
! 2 Warning Signs
View Full Analysis

What is Schott Pharma AG KGaA FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:1SXPD
71GF Score
Schott Pharma AG & CO KGaA CHIX:1SXPD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Schott Pharma AG KGaA (CHIX:1SXPD) Overvalued in 2026?

Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued. The current stock price of €14.47 is trading 28% below its estimated GF Value™ of €20.10.

Key valuation signals for CHIX:1SXPD:

  • FFO:
  • GF Value™: €20.10 vs. price of €14.47 (28% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the CHIX:1SXPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Schott Pharma AG KGaA Business Description

Address Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
71GF Score

Get the complete analysis for CHIX:1SXPD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.47
Price
€20.10
GF Value